Zobrazeno 1 - 10
of 278
pro vyhledávání: '"M. Zierski"'
Autor:
M. Zierski, E. Bek
Publikováno v:
Tubercle. 61:41-49
An analysis is presented of the side effects which occurred in 530 patients treated with 6 months chemotherapy for newly detected pulmonary tuberculosis. Five treatment regimens were used. The initial phase of treatment consisted of daily isoniazid,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d39a59baaeff686f3bcbb3ca181bf70f
https://doi.org/10.1016/0041-3879(80)90060-4
https://doi.org/10.1016/0041-3879(80)90060-4
Autor:
Włodarczyk M; Chair of History of Medicine and Pharmacy, Medical University, Lódź, Poland. docmag@interia.pl
Publikováno v:
Polskie Archiwum Medycyny Wewnetrznej [Pol Arch Med Wewn] 2008 Mar; Vol. 118 (3), pp. 164-6.
Autor:
M, Zierski, J, Graczyk
Publikováno v:
Pneumonologia polska. 45(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::944cea80628918f7f91ee1765a202d60
https://pubmed.ncbi.nlm.nih.gov/854459
https://pubmed.ncbi.nlm.nih.gov/854459
Publikováno v:
European journal of respiratory diseases. 66(4)
A population (n = 526), consisting of employees with COPD, was compared with 2 control populations for the prevalence of Pi-phenotypes. In the patient group, the proportions of ZZ, SZ and MZ were significantly elevated. Among the patient population a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fa0c033b25c0f9fcc1a8a179eb3ca5c6
https://pubmed.ncbi.nlm.nih.gov/3874784
https://pubmed.ncbi.nlm.nih.gov/3874784
Publikováno v:
Praxis und Klinik der Pneumologie. 39(11)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1b420a0d133b3e19ab7cd2f9eb909ec9
https://pubmed.ncbi.nlm.nih.gov/4080664
https://pubmed.ncbi.nlm.nih.gov/4080664
Publikováno v:
Special Problems in Chemotherapy ISBN: 9781468431223
The great value of rifampicin as a suitable anti-tuberculous agent for intermittent therapy has been confirmed in several experimental and clinical studies. Unfortunately our actual knowledge of which size of doses should be chosen for rifampicin in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97ee283177beac88aa3eb0cea86dcbbd
https://doi.org/10.1007/978-1-4684-3120-9_12
https://doi.org/10.1007/978-1-4684-3120-9_12
Publikováno v:
Pneumologie (Stuttgart, Germany). 43(12)
1405 adult patients were selected for assessment who had been newly notified in the years 1986/87 with confirmed diagnosis of active progressive pulmonary tuberculosis who required treatment. Of these, 83.5% excreted tubercle bacilli in the sputum; r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::704863d311db17540ce1e5b0e32ace90
https://pubmed.ncbi.nlm.nih.gov/2622876
https://pubmed.ncbi.nlm.nih.gov/2622876
Autor:
M, Zierski
Publikováno v:
Praxis und Klinik der Pneumologie. 33(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b252b4da382a8cb9f747cb27457c7b76
https://pubmed.ncbi.nlm.nih.gov/493236
https://pubmed.ncbi.nlm.nih.gov/493236
Publikováno v:
European journal of respiratory diseases. 68(1)
During the past decade, six short-course (6-month) chemotherapy regimens were studied in which drugs were given daily and intermittently. Four regimens containing isoniazid, rifampin, and ethambutol caused little toxicity but yielded relapse rates (8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6d8a806fba18d401ab353b79edc9ed52
https://pubmed.ncbi.nlm.nih.gov/3512281
https://pubmed.ncbi.nlm.nih.gov/3512281
Autor:
M, Zierski
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 112(50)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a1ce15e80b7e6ebe40ac0d16097fc664
https://pubmed.ncbi.nlm.nih.gov/3319477
https://pubmed.ncbi.nlm.nih.gov/3319477